A partnership between the agreement recipient, allucent, and biomedical advanced research and development authority (barda) to enhance innovation with decentralized care capabilities and to execute…

Ended Definitive Contract Awarded Last action

Contract number
75A50124C00025
Awardee
Awarding agency
Obligated
$3,159,479

Award facts

Opportunity
Contract value 78% obligated
  • $3,159,479.00 Current, with exercised options
  • $4,039,067.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cary, NC 27513, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 · D-cohre partnership (r & d) $0
Supplemental Agreement for work within scope P00002 · EOI::ending radical and wasteful government DEI programs and preferencing, defending women from gender ideology extremism and restoring biological truth to… $0
Supplemental Agreement for work within scope P00001 $0
Original award $3,159,479

About this award

Written by GovTribe AI ·

On July 8, 2024, the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services awarded a $4.04 million definitive contract to Allucent Government Services (US) LLC to support the D-COHRE Partnership, a research and development initiative designed to enhance innovation through decentralized care capabilities and execute more efficient clinical research. The contract, which carries a firm fixed price and no set-aside designation, is scheduled for completion by July 7, 2029, with performance conducted at Allucent's facility in Cary, North Carolina. This award represents a continuation of ASPR's collaboration with Allucent, leveraging the contractor's extensive experience in clinical trial execution and medical countermeasure development.

Allucent, formerly known as Pharm-Olam LLC, is a clinical research organization with deep expertise across the full clinical trial lifecycle, particularly in infectious disease research and public health preparedness. The company has established itself as a strategic partner to ASPR through a $550 million single-award Indefinite Delivery Vehicle for clinical trial planning and execution services supporting medical countermeasure programs. Allucent's portfolio includes substantial task orders from ASPR, the National Institutes of Health, and the Department of Defense, positioning the company as a key federal contractor for advancing medical research and pandemic preparedness initiatives.

Description

As the agency reported it.

A partnership between the agreement recipient, allucent, and biomedical advanced research and development authority (barda) to enhance innovation with decentralized care capabilities and to execute more efficient and relevant clinical research in the

Quick answers

Who was awarded contract 75A50124C00025?

75A50124C00025 was awarded to Allucent Government Services (Us) LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 8, 2024.

How much is contract 75A50124C00025 worth?

The government has obligated $3,159,479 on 75A50124C00025. Its potential value, with all options, is $4,039,067.

Was contract 75A50124C00025 competed?

The extent of competition for 75A50124C00025 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login